Harlan Levine, M.D., is president of health innovation and policy for City of Hope®. He also serves as the chairman of the board of AccessHopeTM, a spinout company from City of Hope that is focused on serving the employer and payer markets and making leading-edge cancer care available to all regardless of geographical location.
Prior to City of Hope, Dr. Levine held executive roles at UnitedHealth Group, Towers Watson and Anthem Inc. He currently serves as a board member for BioScienceLA, Reimagine Health and Active Life Scientific, and in an advisory capacity for Quantum Health and Laguna Health. In addition, he is a member of the Accessibility and Affordability Working Group for California Institute for Regenerative Medicine and a senior fellow for Health Evolution.
He is certified by the American Board of Internal Medicine and licensed by the Medical Board of California. He earned his undergraduate degree from Harvard College in Cambridge, Massachusetts, and his medical degree from the University of California San Francisco. He interned at Mount Zion Hospital and Medical Center in San Francisco, California, and completed his residency in internal medicine at Cedars-Sinai Health System in Los Angeles, California.
